| Trial Identifier: | 7517-CL-1101 |
| Sponsor: | Astellas Pharma Global Development, Inc. |
| Start Date: | November 2021 |
| Primary Completion Date: | June 2024 |
| Study Completion Date: | June 2024 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| United States of America, GA | Atlanta, GA, United States of America, 30322 |
| United States of America, IA | Iowa City, IA, United States of America, 52242 |
| United States of America, IL | Chicago, IL, United States of America, 60603 |
| United States of America, PA | Pittsburgh, PA, United States of America, 15232 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company